Norway to pay more for essential antibiotics
The maneuver should benefit manufacturers.
The Norwegian Medicines Agency (SLV) is now raising the payment for a group of older antibiotics that risk disappearing from the Norwegian market. These are antibiotics that have had low sales volumes and low prices.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
